直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Advised a global pharma company on loss of exclusivity and enforcement strategy in relation to its platelet inhibitor drug*

Advised a global pharma company on loss of exclusivity and enforcement strategy in relation to its platelet inhibitor drug.

Related Professionals

Jin Ooi
Partner
London
+44 20 7864 2821
Email

Related Practices

Diligence, Licensing, and Opinions

Opinions and Counseling

Related Industries

Life Sciences

Biotechnology

Biologics

*Matter handled prior to joining Finnegan.

Related Experiences

Advised a global innovator pharma company in relation to enforcement issues surrounding its second medical use patent for a chemotherapy medication*

Managed an enforcement program for a globally recognised board game in relation to its trade mark, including a dispute with a major retailer resulting in settlement*

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias*

Advised on and conducted enforcement action against the misuse of a major global retailer in domain names for third party websites*

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia*

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers*

Advised a leading private equity firm on patent litigation and life sciences regulatory aspects on its acquisition of a leading European pharmaceutical company*

Advised a life sciences company in navigating the patent landscape in the DNA sequencing space and preparing to clear the way for its human genomic sequencing technology*

Helping a global technology company develop its AI and NPU portfolios

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP